Maxine Lum Mauricio
Known title: DirectorCIK: 0001663011
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Novanta Shares Rise Amid Positive Analyst Mentions. Recent reports highlight Novanta as a stock gaining attention from Wall Street, with one article noting its shares skyrocketed alongside other names. The company is currently trading near its 52-week low, despite analysts maintaining a higher average target price. This divergence suggests the market is currently pricing in significant caution regarding the stock's high valuation.
Transaction History
| EME | ▲ Buy | Grant | 4 | $0 | 7/31/2026 | View on chart |
| EME | ▲ Buy | Grant | 4 | $0 | 4/30/2026 | View on chart |
| EME | ▼ Sell | Gift | 1,377 | $0 | 3/17/2026 | View on chart |
| EME | ▼ Sell | Open Market | 3,357 | $2.5M | 3/2/2026 | View on chart |
| EME | ▼ Sell | Tax Withholding | 1,709 | $1.2M | 2/27/2026 | View on chart |
| EME | ▲ Buy | Grant | 6 | $0 | 1/30/2026 | View on chart |
| EME | ▲ Buy | Grant | 1,507 | $0 | 1/2/2026 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 1,325 | — | 1/2/2026 | View on chart |
| EME | ▲ Buy | Grant | 3 | $0 | 10/30/2025 | View on chart |
| EME | ▲ Buy | Grant | 3 | $0 | 7/31/2025 | View on chart |
| EME | ▲ Buy | Grant | 8 | $0 | 4/30/2025 | View on chart |
| EME | ▼ Sell | Gift | 250 | $0 | 3/13/2025 | View on chart |
| EME | ▼ Sell | Open Market | 1,250 | $463K | 3/13/2025 | View on chart |
| EME | ▼ Sell | Tax Withholding | 1,690 | $681K | 2/27/2025 | View on chart |
| EME | ▲ Buy | Grant | 8 | $0 | 1/31/2025 | View on chart |
| EME | ▲ Buy | Grant | 1,720 | $0 | 1/2/2025 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 1,217 | — | 1/2/2025 | View on chart |
| EME | ▲ Buy | Grant | 7 | $0 | 10/30/2024 | View on chart |
| EME | ▲ Buy | Grant | 2,500 | $0 | 10/29/2024 | View on chart |
| EME | ▲ Buy | Grant | 10 | $0 | 7/30/2024 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 278 | — | 7/3/2024 | View on chart |
| EME | ▲ Buy | Grant | 2,500 | $0 | 6/6/2024 | View on chart |
| EME | ▼ Sell | Open Market | 4,620 | $1.8M | 5/22/2024 | View on chart |
| EME | ▲ Buy | Grant | 9 | $0 | 4/30/2024 | View on chart |
| EME | ▼ Sell | Gift | 375 | $0 | 2/29/2024 | View on chart |
| EME | ▼ Sell | Tax Withholding | 2,080 | $652K | 2/29/2024 | View on chart |
| EME | ▲ Buy | Grant | 14 | $0 | 1/31/2024 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 464 | — | 1/3/2024 | View on chart |
| EME | ▲ Buy | Grant | 3,478 | $0 | 1/2/2024 | View on chart |
| EME | ▲ Buy | Grant | 3,000 | $0 | 12/29/2023 | View on chart |
| EME | ▲ Buy | Grant | 10 | $0 | 10/30/2023 | View on chart |
| EME | ▲ Buy | Grant | 10 | $0 | 7/31/2023 | View on chart |
| EME | ▲ Buy | Grant | 13 | $0 | 4/28/2023 | View on chart |
| EME | ▼ Sell | Tax Withholding | 1,517 | $251K | 2/24/2023 | View on chart |
| EME | ▼ Sell | Gift | 600 | $0 | 2/24/2023 | View on chart |
| EME | ▲ Buy | Grant | 17 | $0 | 1/31/2023 | View on chart |
| EME | ▼ Sell | Open Market | 2,500 | $374K | 1/17/2023 | View on chart |
| EME | ▲ Buy | Grant | 4,095 | $0 | 1/3/2023 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 359 | — | 1/3/2023 | View on chart |
| EME | ▼ Sell | Open Market | 2,500 | $363K | 12/15/2022 | View on chart |
| EME | ▼ Sell | Open Market | 5,000 | $708K | 10/31/2022 | View on chart |
| EME | ▲ Buy | Grant | 14 | $0 | 10/31/2022 | View on chart |
| EME | ▲ Buy | Grant | 15 | $0 | 7/29/2022 | View on chart |
| EME | ▼ Sell | Gift | 944 | $0 | 5/12/2022 | View on chart |
| EME | ▲ Buy | Grant | 16 | $0 | 4/29/2022 | View on chart |
| EME | ▼ Sell | Tax Withholding | 2,115 | $247K | 2/25/2022 | View on chart |
| EME | ▲ Buy | Grant | 22 | $0 | 1/31/2022 | View on chart |
| NOVT | ▲ Buy | Option Exercise | 531 | — | 1/4/2022 | View on chart |
| EME | ▲ Buy | Grant | 4,389 | $0 | 1/3/2022 | View on chart |
| EME | ▲ Buy | Grant | 15 | $0 | 10/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
EMCOR Group (EME) Highlights Turnaround and Upcoming Earnings
Recent coverage notes that EMCOR is outperforming many construction peers this year and that its turnaround plan, including new petrochemical work, is viewed as a growth catalyst. The stock has slipped even as the broader market improved, while an AI‑focused investor allocated a notable portion of a data‑center contractor portfolio to the company. EMCOR also announced the date for its third‑quarter 2026 earnings release and webcast.
EMCOR Group (EME) Highlights Turnaround and Upcoming Earnings. Recent coverage notes that EMCOR is outperforming many construction peers this year and that its turnaround plan, including new petrochemical work, is viewed as a growth catalyst. The stock has slipped even as the broader market improved, while an AI‑focused investor allocated a notable portion of a data‑center contractor portfolio to the company. EMCOR also announced the date for its third‑quarter 2026 earnings release and webcast.